Drug Search Results
More Filters [+]

QuantideX® qPCR BCR-ABL IS Kit

Alternative Names: QuantideX® qPCR BCR-ABL IS Kit
Latest Update: 2024-05-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Device

Novel Mechanism: No

Modality: Device

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Bio-Techne
Company Location: MINNEAPOLIS MN 55413
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for QuantideX® qPCR BCR-ABL IS Kit

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Chronic Myeloid Leukemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title